H. Uronis

发表

Abstract LB-121: Randomized phase II study of the efficacy and safety of gemcitabine + TH-302 (G+T) vs gemcitabine (G) alone in previously untreated patients with advanced pancreatic cancer

M. Borad, D. Ryan, S. Kroll, 2012 .

A phase 1b/2, open label, dose-escalation study of margetuximab (M) in combination with pembrolizumab (P) in patients with relapsed/refractory advanced HER2+ gastroesophageal (GEJ) junction or gastric (G) cancer.

E. Schmidt, P. Philip, J. Wigginton, 2017 .

A phase Ib/II trial of AMG 655 and panitumumab (pmab) for the treatment (tx) of metastatic colorectal cancer (mCRC): Safety results.

P. Rougier, J. Infante, J. Stephenson, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease.

A. Abernethy, G. Samsa, D. Mccrory, 2011, The Cochrane database of systematic reviews.

Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis

A. Abernethy, G. Samsa, D. Mccrory, 2008, British Journal of Cancer.

Clinical evaluation of nitric oxide responses to anti-VEGF therapy with bevacizumab

Jason D. Allen, H. Hurwitz, J. Bendell, 2007 .

Initial results of a phase II study of oxaliplatin (OX), capecitabine (CAP), bevacizumab (BV), and cetuximab (CET) in the treatment of metastatic colorectal cancer (mCRC)

H. Hurwitz, J. Bendell, G. Blobe, 2008 .

Patterns of recurrence after trimodality therapy for esophageal cancer

C. Willett, T. D’amico, J. Pura, 2014, Cancer.

Preoperative chemoradiotherapy for locally advanced gastric cancer

C. Willett, D. Tyler, B. Czito, 2013, Radiation oncology.

Phase I study of pazopanib plus TH-302 in advanced solid tumors

H. Hurwitz, R. Riedel, D. Niedzwiecki, 2017, Cancer Chemotherapy and Pharmacology.

Is follow‐up CT imaging of the chest and abdomen necessary after preoperative neoadjuvant therapy in rectal cancer patients without evidence of metastatic disease at diagnosis?

A. Neville, T. Jaffe, M. Bashir, 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors

H. Hurwitz, J. Bendell, H. Pang, 2014, Investigational New Drugs.

Is bevacizumab effective and safe in combination with chemotherapy in patients with colorectal cancer?

H. Hurwitz, H. Uronis, 2007, Nature Clinical Practice Oncology.

Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer

S. McCall, H. Hurwitz, G. Blobe, 2014, Investigational New Drugs.

A phase I study of bevacizumab (B) in combination with everolimus (E) and erlotinib (E) in advanced cancer (BEE)

H. Hurwitz, J. Bendell, G. Blobe, 2011, Cancer Chemotherapy and Pharmacology.

A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial)

H. Hurwitz, D. Niedzwiecki, G. Blobe, 2019, Cancer Chemotherapy and Pharmacology.

Palliative management of refractory dyspnea in COPD

A. Abernethy, D. Currow, H. Uronis, 2006, International journal of chronic obstructive pulmonary disease.

Role of Chemotherapy and Radiation Therapy in the Management of Gastric Adenocarcinoma.

H. Uronis, M. Palta, D. Spiegel, 2017, The Surgical clinics of North America.

NCI9673: A multi-institutional eETCTN phase II study of nivolumab in refractory metastatic squamous cell carcinoma of the anal canal (SCCA).

P. Sharma, Preet Paul Singh, T. Bekaii-Saab, 2016 .

Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer.

H. Hurwitz, D. Niedzwiecki, G. Blobe, 2021, The oncologist.

Quality management of potential chemotherapy-induced neutropenic complications: evaluation of practice in an academic medical center

A. Abernethy, A. Coan, H. Uronis, 2009, Supportive Care in Cancer.

A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer.

H. Hurwitz, R. Riedel, H. Pang, 2018, The oncologist.

Management of dyspnea in patients with chronic obstructive pulmonary disease

A. Abernethy, D. Currow, H. Uronis, 2009, Wiener Medizinische Wochenschrift.

Pharmacological management of breathlessness in advanced disease

A. Abernethy, D. Currow, H. Uronis, 2008 .

Oxygen for relief of dyspnea: what is the evidence?

A. Abernethy, H. Uronis, 2008, Current opinion in supportive and palliative care.

Oxygen for relief of dyspnoea in people with chronic obstructive pulmonary disease who would not qualify for home oxygen: a systematic review and meta-analysis

A. Abernethy, G. Samsa, D. Mccrory, 2014, Thorax.

Palliative oxygen for non‐hypoxaemic chronic obstructive pulmonary disease

A. Abernethy, G. Samsa, D. Mccrory, 2007 .

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.

J. Ajani, T. Zander, A. Lièvre, 2021, The New England journal of medicine.

Assessment of the psychometric properties of an English version of the cancer dyspnea scale in people with advanced lung cancer.

A. Abernethy, H. Bosworth, D. Currow, 2012, Journal of pain and symptom management.

A phase I study of gemcitabine + dasatinib (gd) or gemcitabine + dasatinib + cetuximab (GDC) in refractory solid tumors

H. Hurwitz, J. Bendell, D. Niedzwiecki, 2019, Cancer Chemotherapy and Pharmacology.

Bevacizumab (B) plus everolimus (E) in refractory metastatic colorectal cancer (mCRC).

H. Hurwitz, J. Bendell, G. Blobe, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Safety at the Time of the COVID-19 Pandemic: How to Keep our Oncology Patients and Healthcare Workers Safe.

R. Fonseca, L. Shulman, A. Mishra, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

Carcinoma of the Ampulla of Vater: Patterns of Failure Following Resection and Benefit of Chemoradiotherapy

C. Willett, H. Hurwitz, D. Tyler, 2012, Annals of Surgical Oncology.

A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas.

H. Hurwitz, J. Bendell, G. Blobe, 2013, The oncologist.

A case report of microsatellite instability (MSI)-high, HER2 amplified pancreatic adenocarcinoma with central nervous system metastasis.

C. Anders, J. Abbruzzese, M. Morse, 2021, AME case reports.

Anal cancer: an overview.

J. Bendell, H. Uronis, 2007, The oncologist.

Hepatic Artery Infusion Pumps

M. D'Angelica, W. Jarnagin, N. Kemeny, 2022, Annals of surgery.

CHLAMYDIA INFECTION

A. L. Wong, J. Belmont, F. Lammert, 2001 .

Metastatic Pancreatic Cancer: ASCO Guideline Update.

T. Conroy, P. Philip, M. Shah, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial.

J. Lacy, S. Park, Y. Bang, 2020, The Lancet. Oncology.

A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors

H. Hurwitz, R. Riedel, J. Bendell, 2012, Cancer Chemotherapy and Pharmacology.

Phase Ib/II study of pembrolizumab with lanreotide depot for advanced, progressive gastroenteropancreatic neuroendocrine tumors (PLANET).

H. Hurwitz, D. Hsu, D. Niedzwiecki, 2021 .

Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors

H. Hurwitz, P. Marcom, M. Morse, 2012, Cancer Chemotherapy and Pharmacology.

Companion Diagnostics and Cancer Biomarkers Biomarker Signatures Correlate with Clinical Outcome in Refractory Metastatic Colorectal Cancer Patients Receiving Bevacizumab and Everolimus

H. Hurwitz, H. Pang, Yingmiao Liu, 2022 .

Implementation of a Hepatic Artery Infusion Program: Initial Patient Selection and Perioperative Outcomes of Concurrent Hepatic Artery Infusion and Systemic Chemotherapy for Colorectal Liver Metastases

P. Allen, J. Creasy, B. Wildman-Tobriner, 2020, Annals of Surgical Oncology.

A phase II study of axalimogene filolisbac for patients with previously treated, unresectable, persistent/recurrent loco-regional or metastatic anal cancer

M. Fakih, H. Hochster, V. Morris, 2020, Oncotarget.

A phase I study of ABT-510 plus bevacizumab in advanced solid tumors

H. Hurwitz, J. Bendell, G. Blobe, 2013, Cancer medicine.

Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update.

A. Khorana, P. Philip, M. Shah, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

A. Khorana, P. Philip, M. Shah, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Virtual reality for improving pain and pain-related symptoms in patients with advanced stage colorectal cancer: A pilot trial to test feasibility and acceptability

F. Keefe, T. Somers, Joseph G. Winger, 2022, Palliative and Supportive Care.

S1478951521002017jra 1..11

F. Keefe, T. Somers, Joseph G. Winger, 2022 .

Feasibility, engagement, and acceptability of a behavioral pain management intervention for colorectal cancer survivors with pain and psychological distress: data from a pilot randomized controlled trial

F. Keefe, T. Somers, Joseph G. Winger, 2021, Supportive Care in Cancer.

Antitumor activity of margetuximab (M) plus pembrolizumab (P) in patients (pts) with advanced HER2+ (IHC3+) gastric carcinoma (GC).

J. Lacy, S. Park, Y. Bang, 2019, Journal of Clinical Oncology.

The Use of Re-irradiation in Locally Recurrent, Non-metastatic Rectal Cancer

C. Willett, B. Czito, M. Susko, 2016, Annals of Surgical Oncology.

A phase II trial of bevacizumab plus everolimus for patients with refractory metastatic colorectal cancer.

H. Hurwitz, J. Bendell, G. Blobe, 2011, The oncologist.

Validation of the Patient Care Monitor (Version 2.0): a review of system assessment instrument for cancer patients.

Amy P Abernethy, April Coan, Rebecca A Shelby, 2010, Journal of pain and symptom management.

A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors

H. Hurwitz, J. Bendell, H. Pang, 2015, Cancer Chemotherapy and Pharmacology.

LBA9_PR Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiation therapy (CRT): First results of the CheckMate 577 study

J. Ajani, T. Zander, A. Lièvre, 2020 .

Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer.

M. Borad, D. Ryan, S. Kroll, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Margetuximab (M) plus pembrolizumab (P) in ERBB2-amplified PD-L1+ gastroesophageal adenocarcinoma (GEA) post trastuzumab (T).

J. Lacy, S. Park, Y. Bang, 2018 .

A randomized pilot trial of a videoconference couples communication intervention for advanced GI cancer

D. Baucom, F. Keefe, L. Porter, 2017, Psycho-oncology.

Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?

C. Willett, H. Hurwitz, D. Tyler, 2012, Journal of surgical oncology.

Bevacizumab (B) plus everolimus (E) and panitumumab (P) in refractory advanced solid tumors.

H. Hurwitz, R. Riedel, J. Bendell, 2016, Journal of Clinical Oncology.

CT-derived body composition measurements as predictors for neoadjuvant treatment tolerance and survival in gastroesophageal adenocarcinoma

K. Lafata, M. Bashir, H. Uronis, 2022, Abdominal Radiology.

A phase I study of erlotinib, bevacizumab, and external beam radiation therapy (RT) for patients with localized pancreatic carcinoma (PC).

C. Willett, H. Hurwitz, D. Tyler, 2011, Journal of Clinical Oncology.

mHealth Coping Skills Training for Symptom Management (mCOPE) for colorectal cancer patients in early to mid-adulthood: Study protocol for a randomized controlled trial.

Caroline S. Dorfman, F. Keefe, T. Somers, 2023, Contemporary clinical trials communications.

Hepatic artery infusion for unresectable colorectal cancer liver metastases: Palliation and conversion.

J. Strickler, H. Uronis, S. Zani, 2023, Surgery.

A phase I clinical trial of navitoclax, a targeted high-affinity Bcl-2 family inhibitor, in combination with gemcitabine in patients with solid tumors

G. Shapiro, H. Hurwitz, T. Busman, 2014, Investigational New Drugs.

Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors.

H. Hurwitz, J. Bendell, M. Morse, 2012, Journal of Clinical Oncology.

Preoperative chemoradiotherapy for locally advanced gastric cancer

C. Willett, D. Tyler, B. Czito, 2013, Radiation oncology.

Radiotherapy in the treatment of patients with unresectable extrahepatic cholangiocarcinoma.

C. Willett, R. Clough, H. Hurwitz, 2011, International journal of radiation oncology, biology, physics.

Patterns of failure for stage I ampulla of Vater adenocarcinoma: a single institutional experience.

C. Willett, S. McCall, D. Tyler, 2014, Journal of gastrointestinal oncology.

The role of local excision in invasive adenocarcinoma of the ampulla of Vater.

C. Willett, S. McCall, D. Tyler, 2013, Journal of gastrointestinal oncology.

1381P Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiotherapy (CRT): 14-month follow-up of CheckMate 577

J. Ajani, T. Zander, A. Lièvre, 2021, Annals of Oncology.

Chronic Idiopathic Intestinal Pseudo-obstruction

A. L. Wong, J. Belmont, M. Dichgans, 2011 .

[Cutaneous amyloidoses].

A. L. Wong, J. Belmont, D. Roden, 1990, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

Adjuvant nivolumab (NIVO) in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiotherapy (CRT): Expanded efficacy and safety analyses from CheckMate 577.

J. Ajani, T. Zander, A. Lièvre, 2021 .

Phase 1b/2 study of margetuximab (M) plus pembrolizumab (P) in advanced HER2+ gastroesophageal junction (GEJ) or gastric (G) adenocarcinoma (GEA).

S. Park, Y. Bang, Yoon-Koo Kang, 2018 .

[Chronic venous insufficiency].

V Wienert, G Hauer, A Lentner, 1996, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer

K. Blackwell, H. Hurwitz, P. Marcom, 2019, BMC Cancer.

A phase I study of bevacizumab (BV) plus ABT-510 in patients with advanced solid tumors

H. Hurwitz, J. Bendell, M. Morse, 2007 .

Preoperative chemoradiotherapy for locally advanced gastric cancer

C. Willett, D. Tyler, B. Czito, 2013, Radiation Oncology.

Congenital rubella syndrome

S. Lalani, K. Chayama, A. Cleare, 2020, Definitions.

Congenital dysfibrinogenemia.

S. Lalani, K. Chayama, A. Cleare, 1984, Current problems in clinical biochemistry.

Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL)

S. Lalani, K. Chayama, M. Vikkula, 1999, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

P PROGNOSIS IMPACT OF POSTOPERATIVE RADIATION IN PATIENTS WITH RADICAL ESOPHAGECTOMY AND PATHOLOGIC LYMPH NODES POSITIVE ESOPHAGEAL CANCER

J. Reis-Filho, M. Borad, D. Ryan, 2012 .